Paulus Wolfgang E, Schwamborn Carolin, Friebe-Hoffmann Ulrike
Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Ulm, Ulm, Deutschland.
Beratungsstelle für Reproduktionstoxikologie, Universitätsfrauenklinik Ulm, Prittwitzstr. 43, 89075, Ulm, Deutschland.
HNO. 2025 Sep;73(9):661-672. doi: 10.1007/s00106-025-01648-7. Epub 2025 Aug 4.
Breastmilk is well established as the best source of nutrition for infants. Any interruption to breastfeeding comes with risks such as mastitis, decreased breastmilk supply, infant bottle refusal, and infant allergic reaction if formula is used. The majority of common medications used in general otolaryngology are safe for breastfeeding patients. Insufficient knowledge can lead to clinicians and patients alike being concerned about continued breastfeeding, resulting in interruption or cessation of breastfeeding. On the other hand, much-needed treatment is often withheld for fear of putting the infant at risk from contaminated breastmilk, which can disrupt the mother's wellbeing and, in turn, disturb a successful breastfeeding relationship. The aim of the present work is to present a structured "guideline for practice" pertaining to medication that can be used during lactation for treating medical conditions of the ear, nose, and throat.
母乳作为婴儿最佳的营养来源已得到充分认可。母乳喂养的任何中断都伴随着风险，如乳腺炎、母乳供应减少、婴儿拒奶瓶以及如果使用配方奶则会出现婴儿过敏反应。普通耳鼻喉科使用的大多数常用药物对哺乳期患者是安全的。知识不足可能导致临床医生和患者都担心继续母乳喂养，从而导致母乳喂养中断或停止。另一方面，由于担心婴儿因受污染的母乳而面临风险，急需的治疗往往被推迟，这可能会扰乱母亲的健康，进而破坏成功的母乳喂养关系。本研究的目的是提出一份结构化的“实践指南”，涉及哺乳期可用于治疗耳、鼻、喉疾病的药物。
